Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL) (KLL3)

Tampere University Hospital

Status: Completed

Conditions: CLL

Study type: Observational

Funder types: Other

Identifiers

NCT01397916

CLL-IDO

Details and patient eligibility

About

The Activity of Indoleamine 2,3-dioxygenase in patients with Chronic Lymphocytic Leukemia (CLL) is studied.

Full description

The Activity of Indoleamine 2,3-dioxygenase in patients with Chronic Lymphocytic Leukemia (CLL)is studied in patients and healthly controls.

Enrollment: 73 patients

Sex: All

Ages: 15 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients with CLL and lymphocyte count > 10 x 109/l

Exclusion criteria

• Acute infection

Trial design

73 participants in 2 patient groups

CLL-patients

Controls